| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$162,251,771 |
|
|
|
Indirect Value
|
$375,195,594 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$537,447,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-03 |
4 |
A |
$4.33 |
$800,569 |
I/I |
184,889 |
2,276,030 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-23 |
4 |
S |
$18.48 |
$4,644,671 |
I/I |
(251,335) |
2,280,894 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2009-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
2,311,487 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2010-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,200 |
2,326,687 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
4,592,086 |
2,327,603 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive OfficerOfficer |
• • • |
2013-08-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,375,298 |
|
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-28 |
4 |
A |
$5.46 |
$999,942 |
I/I |
174,954 |
2,422,517 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-22 |
4 |
S |
$17.49 |
$13,675,099 |
I/I |
(781,881) |
2,430,247 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-07-31 |
4 |
A |
$7.76 |
$1,000,227 |
I/I |
128,235 |
2,524,944 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-08-30 |
4 |
A |
$6.65 |
$1,000,282 |
I/I |
137,353 |
2,632,209 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-09-30 |
4 |
A |
$5.99 |
$1,000,162 |
I/I |
164,134 |
2,762,970 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-21 |
4 |
S |
$17.15 |
$2,765,369 |
I/I |
(161,246) |
2,894,871 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-10-31 |
4 |
A |
$5.54 |
$999,513 |
I/I |
170,697 |
2,897,598 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-16 |
4 |
S |
$17.24 |
$1,644,058 |
I/I |
(95,363) |
2,985,054 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-15 |
4 |
S |
$17.15 |
$1,569,928 |
I/I |
(91,541) |
3,041,722 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-11-29 |
4 |
A |
$5.35 |
$1,000,123 |
I/I |
185,079 |
3,047,141 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-14 |
4 |
S |
$17.36 |
$5,262,996 |
I/I |
(303,168) |
3,096,119 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-12-31 |
4 |
A |
$5.66 |
$1,000,640 |
I/I |
175,879 |
3,188,586 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-10 |
4 |
S |
$17.08 |
$3,466,540 |
I/I |
(202,959) |
3,276,273 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2012-05-15 |
4 |
B |
$7.35 |
$3,142,720 |
I/I |
427,581 |
3,333,528 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-06-20 |
4 |
B |
$16.49 |
$98,693 |
I/I |
5,985 |
3,380,985 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2009-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,390,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-09 |
4 |
S |
$17.48 |
$3,900,260 |
I/I |
(223,127) |
3,396,879 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2010-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,410,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,430,000 |
0 |
- |
|
271 Records found
|
|
Page 7 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
